Oppenheimer Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-31,627	Closed	-$2.51M	–	1186
2022 Q3	$2.51M	Sell	31,627 -8	-0%	-$674	0.04%	400
2022 Q2	$2.35M	Buy	31,635 +3	+0%	+$225	0.04%	424
2022 Q1	$2.84M	Sell	31,632 -4,545	-13%	-$420K	0.04%	427
2021 Q4	$4.05M	Sell	36,177 -576	-2%	-$69.5K	0.05%	348
2021 Q3	$4.62M	Buy	36,753 +3,329	+10%	+$429K	0.07%	317
2021 Q2	$4.53M	Buy	33,424 +848	+3%	+$111K	0.06%	319
2021 Q1	$4.42M	Buy	32,576 +658	+2%	+$98.5K	0.07%	309
2020 Q4	$4.49M	Sell	31,918 -1,414	-4%	-$181K	0.08%	293
2020 Q3	$3.71M	Buy	33,332 +28,531	+594%	+$3.2M	0.07%	299
2020 Q2	$537K	Sell	4,801 -432	-8%	-$42.5K	0.01%	784
2020 Q1	$405K	Sell	5,233 -315	-6%	-$27.9K	0.01%	795
2019 Q4	$528K	Sell	5,548 -75	-1%	-$6.49K	0.01%	803
2019 Q3	$429K	Sell	5,623 -297	-5%	-$24.7K	0.01%	845
2019 Q2	$519K	Sell	5,920 -366	-6%	-$31.2K	0.01%	804
2019 Q1	$569K	Sell	6,286 -410	-6%	-$34.9K	0.01%	764
2018 Q4	$480K	Sell	6,696 -281	-4%	-$22.6K	0.01%	778
2018 Q3	$669K	Sell	6,977 -192	-3%	-$18.6K	0.01%	726
2018 Q2	$682K	Sell	7,169 -105	-1%	-$9.65K	0.02%	705
2018 Q1	$638K	Sell	7,274 -1,436	-16%	-$131K	0.02%	721
2017 Q4	$754K	Hold	8,710	–	–	0.02%	684
2017 Q3	$754K	Buy	8,710 +6,923	+387%	+$555K	0.02%	687
2017 Q2	$138K	Sell	1,787 -2,352	-57%	-$167K	﹤0.01%	1118
2017 Q1	$287K	Buy	+4,139	New	+$278K	0.01%	946